Fineline Cube

Follow:
14398 Articles
Genhouse Bio's MAT2A Inhibitor GH31 Wins NMPA and FDA Clinical Trial Approvals
CompanyDrug

Genhouse Bio’s MAT2A Inhibitor GH31 Wins NMPA and FDA Clinical Trial Approvals

Touchstone Medical Partners with INSPUR to Advance Healthcare AI and Medical Robots
CompanyDeals

Touchstone Medical Partners with INSPUR to Advance Healthcare AI and Medical Robots

Yifan Pharmaceutical Licenses ACT001 for SCLC Brain Metastases Across 12 Asian Markets
CompanyDeals

Yifan Pharmaceutical Licenses ACT001 for SCLC Brain Metastases Across 12 Asian Markets

Humanwell Healthcare's HW221043 Receives NMPA Approval for Advanced Solid Tumor Trials
CompanyDrug

Humanwell Healthcare’s HW221043 Receives NMPA Approval for Advanced Solid Tumor Trials

Bio-Sincerity Partners with Xellar on AI Organoid Chip Drug Discovery Platform
CompanyDeals

Bio-Sincerity Partners with Xellar on AI Organoid Chip Drug Discovery Platform

Frontier Biotech's FB7013 Wins NMPA IND for MASP‑2 siRNA in IgA Nephropathy
CompanyDrug

Frontier Biotech’s FB7013 Wins NMPA IND for MASP‑2 siRNA in IgA Nephropathy

Insilico Medicine Partners with Servier on $888 Million AI Oncology Deal
CompanyDeals

Insilico Medicine Partners with Servier on $888 Million AI Oncology Deal

Kelun-Biotech's sac-TMT Wins Breakthrough Therapy Designation for First‑Line NSCLC
CompanyDrug

Kelun-Biotech’s sac-TMT Wins Breakthrough Therapy Designation for First‑Line NSCLC

Kangtai Biological Co‑founds Beijing Laboratory to Advance Synthetic Immunology and Vaccine Manufacturing
CompanyDeals

Kangtai Biological Co‑founds Beijing Laboratory to Advance Synthetic Immunology and Vaccine Manufacturing

Kelun-Biotech's ITGB6 ADC SKB105 Wins NMPA IND Approval
CompanyDrug

Kelun-Biotech’s ITGB6 ADC SKB105 Wins NMPA IND Approval

Huadong Medicine Licenses MC2's PAD‑Based Biomee Skincare for Greater China
CompanyDeals

Huadong Medicine Licenses MC2’s PAD‑Based Biomee Skincare for Greater China

CMS Unveils BALANCE Model to Expand GLP-1 Access for Medicare/Medicaid
Policy / Regulatory

CMS Unveils BALANCE Model to Expand GLP-1 Access for Medicare/Medicaid